DocGo Inc. (DCGO)
$0.18
+0.00 (+1.98%)Delayed quote.
Price history
Daily close- Start
- $1.02
- Latest close
- $0.18
- Period change
- -82.84%
- Period low
- $0.17
- Period high
- $1.08
Key metrics
- Market cap
- $17.32M
- Volume
- 1.02M
- Average volume
- 737.1K
- 52-week range
- $0.17 – $1.10
- Beta
- 1.00
- Last dividend
- —
- EPS (TTM)
- -$1.85
- P/E ratio
- -0.48
- Revenue (TTM)
- $297.34M
- Net income (TTM)
- -$181.25M
- Total assets
- $173.90M
- Total debt
- $24.64M
- Cash and equivalents
- $19.11M
Key financials (trailing twelve months).
Company profile
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NASDAQ
- CEO
- Lee Bienstock
- Employees
- 3,568
- Headquarters
- New York City, NY, US
- IPO date
- 2020-12-17
- Website
- https://www.docgo.com
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Revenue | $322.20M | $616.56M | $624.29M |
| Gross profit | $98.76M | $213.57M | $195.38M |
| Operating income | -$89.16M | $28.69M | $15.05M |
| EBITDA | -$170.82M | $45.56M | $32.73M |
| Net income | -$182.40M | $19.99M | $6.86M |
| Diluted EPS | -$1.84 | $0.18 | $0.06 |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $51.02M | $89.24M | $59.29M |
| Total assets | $217.10M | $455.62M | $490.45M |
| Total liabilities | $91.23M | $140.44M | $185.28M |
| Total debt | $29.18M | $57.19M | $46.50M |
| Shareholders’ equity | $144.01M | $320.92M | $300.79M |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | $34.45M | $70.34M | -$64.22M |
| Capital expenditure | -$7.43M | -$5.84M | -$10.13M |
| Free cash flow | $27.02M | $64.50M | -$74.35M |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $73.43M | $73.42M | $75.55M | $74.94M | $70.81M | $80.42M |
| Gross profit | $24.46M | $22.41M | $23.88M | $24.36M | $18.13M | $25.42M |
| Operating income | -$17.28M | -$17.92M | -$18.71M | -$32.44M | -$41.98M | -$17.48M |
| EBITDA | $2.64T | -$15.15M | -$13.93M | -$107.74M | -$21.27M | -$13.49M |
| Net income | -$16.60M | -$15.82M | -$14.76M | -$134.07M | -$27.77M | -$11.16M |
| Diluted EPS | -$0.17 | -$0.16 | -$0.15 | -$1.37 | -$0.28 | -$0.11 |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $19.11M | $25.23M | $35.68M | $51.02M | $73.36M | $104.16M |
| Total assets | $173.90M | $186.82M | $209.23M | $217.10M | $353.78M | $408.26M |
| Total liabilities | $94.92M | $91.04M | $98.02M | $91.23M | $93.12M | $120.53M |
| Total debt | $24.64M | $25.91M | $28.51M | $29.18M | $29.46M | $60.45M |
| Shareholders’ equity | $105.08M | $119.05M | $132.31M | $144.01M | $270.53M | $297.28M |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$3.62M | -$9.24M | -$4.66M | -$10.47M | $1.66M | $34.04M |
| Capital expenditure | -$120.8K | -$320.8K | -$430.3K | -$2.13M | -$1.56M | -$2.01M |
| Free cash flow | -$3.74M | -$9.56M | -$5.09M | -$12.60M | $101.2K | $32.04M |